Category Archives: News

SOM Biotech attended the FDA Workshop

SOM Biotech at the FDA Workshop

SOM Biotech attended the FDA Workshop “Repurposing Off-Patent Drugs: Research & Regulatory Challenge” on December 5th -6th– in Rockville, USA. The workshop aimed at exploring opportunities and challenges in assessing the safety and efficacy of repurposed drugs, as well as exploring several drug development pathways for treatments, with a specific focus on orphan diseases. Núria …

SOM Biotech at the 10th Drug Discovery Innovation Programme

SOM Biotech participated in the 10th Drug Discovery Innovation Programme that took place on November 28th -29th- in Barcelona, Spain. Luca Signorile – Computational Chemist of SOM Biotech –performed the presentation on the topic “Re-Discovering Drugs: Advantages, Perspectives, and the role of AI.” During his speech, he gave an insight into the computational side of …

SOM Biotech at the Clinical Trials Europe 2019 conference

SOM Biotech has participated in the “Clinical Trials Europe 2019” conference, that took place on November 19th -21st- in Barcelona, Spain. The “Clinical Trials Europe 2019”, one of the leading platforms to build partnerships to develop clinical trials, attracts a wide range of innovative research centers and business development teams from biotech and pharma companies. …

SOM Biotech at the 10th World Orphan Drug Congress 2019

SOM Biotech participated in the World Orphan Drug Congress Europe 2019 on November 12th -14th– in Barcelona, Spain, where the company was a Showcase Sponsor. Raul Insa – CEO of SOM Biotech – presented “Case study: Systematic drug re-innovation and clinical evidence in orphan diseases”. SOM Biotech shared its latest findings in drug discovery and …

SOM Biotech at European Conference on Recent Advances in Lysosomal Diseases

Gal·la Pericot, R&D Manager at SOM Biotech, attended the European Conference on Recent Advances in Lysosomal Diseases, which took place on 24-25 October 2019 in London, UK. The main objective of the conference was sharing of innovative knowledge on the development of new therapeutic modalities for treating disorders linked to the lysosomal storage in the cells, …

SOM Biotech at Bio-Europe 2019

SOM Biotech will participate in the 25th Annual International Partnering Conference “Bio-Europe” on November 10th -13th– in Hamburg, Germany. The conference, Europe´s largest life science partnering venue, is one of the most relevant events to meet with world-leading life science partners, investors, and industry experts. Raul Insa – CEO of SOM Biotech – and Maria …

SOM Biotech at the 19th Annual Schrödinger European User Group Meeting

Luca Signorile, the Senior Computational Chemist at SOM Biotech, participated in the 19th Annual Schrödinger European User Group Meeting, that took place in Berlin on September 25th-27th. The Meeting aimed at illustrating how the capabilities of the Schrödinger software can be efficiently applied to drug discovery to increase research productivity. Science and Technology are the …

Advisor to the Board of Directors of SOM Biotech ran the third annual Bay Area Fox Trot 5K Run/Walk for Parkinson’s Research

 Dr. Joaquim Trias, Advisor to the Board of Directors of SOM Biotech ran the third annual Bay Area Fox Trot 5K Run/Walk for Parkinson’s Research, last October 13th Sunday in San Mateo. The run was organized by The Michel J. Fox Foundation, a prestigious organization launched in year 2000 by the iconic actor Michael J. …

SOM Biotech aims to strengthen its communication and investor relations strategy with the support of Maqua Capital

As an essential part of SOM  Biotech´s strategy to strengthen its visibility within the investment community and with all its stakeholders, the company has hired the services of Maqua Capital, a consulting firm specialized in Investor Relations and Financial Communication. Maqua Capital will design and implement a strategic corporate communication and investor relations plan to …

SOM Biotech attended 3rd “Hard Reg Café” meeting dedicated to the topic of FDA approval for new drugs

Dr. Maria Zimina, Business Development Manager at SOM Biotech, attended “Hard Reg Café” of Regulatory Affairs meeting that took place on June 5 at the Barcelona Science Park (www.pcb.ub.edu). The event was organized by the CataloniaBio & HealthTech Regulatory Affairs Workgroup with the support of ACCIÓ (Government of Catalonia). The main objective of the meeting …